Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from IDT Australia Limited ( (AU:IDT) ) is now available.
IDT Australia Limited has announced the cessation of 164,000 ordinary fully paid shares following the lapse of conditional rights to these securities, after the specified conditions were not met or became incapable of being satisfied as of 29 September 2025. The reduction in potential issued capital reflects the non-vesting of these conditional rights, which may marginally affect future dilution expectations for existing shareholders but does not alter the company’s current issued share capital structure.
The most recent analyst rating on (AU:IDT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on IDT Australia Limited stock, see the AU:IDT Stock Forecast page.
More about IDT Australia Limited
IDT Australia Limited is an Australian pharmaceutical manufacturer listed on the ASX, operating in the life sciences sector and focused on the development and production of specialty medicines and related products.
Average Trading Volume: 269,516
Technical Sentiment Signal: Sell
Current Market Cap: A$23.04M
For an in-depth examination of IDT stock, go to TipRanks’ Overview page.